Wegovy May Be Valuable New Option for Heart Failure Patients
FRIDAY, Aug. 25, 2023 -- Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.
Now, injected Wegovy could prove a boon...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cardiology | Diabetes | Eating Disorders & Weight Management | Endocrinology | General Medicine | Heart | Heart Failure | Obesity | Weight Loss